Nermin Ali

631 total citations
18 papers, 506 citations indexed

About

Nermin Ali is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nermin Ali has authored 18 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nermin Ali's work include Bladder and Urothelial Cancer Treatments (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Renal cell carcinoma treatment (2 papers). Nermin Ali is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Renal cell carcinoma treatment (2 papers). Nermin Ali collaborates with scholars based in Japan, Egypt and United Kingdom. Nermin Ali's co-authors include Koichiro Tsuchiya, Toshiaki Tamaki, Masanori Yoshizumi, Yoshiko Fujita, Yuki Izawa, Yasuhisa Kanematsu, Shoji Kagami, Moe H. Kyaw, Hala O. El‐Mesallamy and Nadia Μ. Hamdy and has published in prestigious journals such as Endocrinology, Infection and Immunity and Molecular Pharmacology.

In The Last Decade

Nermin Ali

18 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nermin Ali Japan 13 278 82 76 68 64 18 506
Lingyun Zheng China 15 379 1.4× 110 1.3× 56 0.7× 65 1.0× 71 1.1× 35 649
Xiao‐Yan Bai China 14 311 1.1× 105 1.3× 70 0.9× 56 0.8× 38 0.6× 31 599
Nelson E. Bruno United States 14 202 0.7× 59 0.7× 30 0.4× 80 1.2× 76 1.2× 18 561
E Liong Hong Kong 11 177 0.6× 59 0.7× 85 1.1× 42 0.6× 39 0.6× 15 429
Jinge Kong China 10 192 0.7× 142 1.7× 71 0.9× 39 0.6× 73 1.1× 13 518
Shengkai Zuo China 16 279 1.0× 75 0.9× 74 1.0× 83 1.2× 116 1.8× 30 613
Maria Teresa Rizzo United States 13 254 0.9× 83 1.0× 32 0.4× 86 1.3× 56 0.9× 40 601
Jutta Meyer-Kirchrath Germany 15 211 0.8× 63 0.8× 52 0.7× 53 0.8× 45 0.7× 24 652
Koji Yamamoto Japan 17 400 1.4× 60 0.7× 90 1.2× 54 0.8× 175 2.7× 35 788
Jingjing Wu China 14 309 1.1× 112 1.4× 45 0.6× 31 0.5× 49 0.8× 27 535

Countries citing papers authored by Nermin Ali

Since Specialization
Citations

This map shows the geographic impact of Nermin Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nermin Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nermin Ali more than expected).

Fields of papers citing papers by Nermin Ali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nermin Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nermin Ali. The network helps show where Nermin Ali may publish in the future.

Co-authorship network of co-authors of Nermin Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Nermin Ali. A scholar is included among the top collaborators of Nermin Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nermin Ali. Nermin Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ali, Nermin, Nadia Μ. Hamdy, Abdullah Ahmed Gibriel, & Hala O. El‐Mesallamy. (2021). Investigation of the relationship between CTLA4 and the tumor suppressor RASSF1A and the possible mediating role of STAT4 in a cohort of Egyptian patients infected with hepatitis C virus with and without hepatocellular carcinoma. Archives of Virology. 166(6). 1643–1651. 45 indexed citations
2.
3.
Çetinkaya, Servet, et al.. (2018). Influence of Incision Size on Dry Eye Symptoms in the Small Incision Lenticule Extraction Procedure. Cornea. 38(1). 18–23. 6 indexed citations
4.
Ali, Nermin, et al.. (2010). Renal cancer in Maiduguri: an 8-year review of clinico-pathological pattern. Sahel Medical Journal. 12(1). 1 indexed citations
5.
Harnden, Patricia, Nermin Ali, Patrick Royston, et al.. (2008). Prognostic factors for renal cell carcinoma. Cancer Treatment Reviews. 34(5). 407–426. 21 indexed citations
6.
Ewis, Ashraf A., Nermin Ali, Kazuaki Kajimoto, et al.. (2007). Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray. Urologic Oncology Seminars and Original Investigations. 25(2). 120–127. 4 indexed citations
7.
Fukumori, Tomoharu, Ashraf A. Ewis, Nermin Ali, et al.. (2006). Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results. Urologic Oncology Seminars and Original Investigations. 24(2). 109–115. 16 indexed citations
8.
Fukumori, Tomoharu, Hiroyoshi Nakatsuji, Masaaki Nishitani, et al.. (2006). Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. British Journal of Urology. 97(6). 1202–1207. 38 indexed citations
9.
Ali, Nermin, Masanori Yoshizumi, Seiji Yano, et al.. (2006). The Novel Src Kinase Inhibitor M475271 Inhibits VEGF-Induced Vascular Endothelial-Cadherin and β-Catenin Phosphorylation but Increases Their Association. Journal of Pharmacological Sciences. 102(1). 112–120. 11 indexed citations
10.
Fujita, Yoshiko, Masanori Yoshizumi, Yuki Izawa, et al.. (2005). Transactivation of Fetal Liver Kinase-1/Kinase-Insert Domain-Containing Receptor by Lysophosphatidylcholine Induces Vascular Endothelial Cell Proliferation. Endocrinology. 147(3). 1377–1385. 26 indexed citations
11.
Ali, Nermin, Masanori Yoshizumi, Yoshiko Fujita, et al.. (2005). A Novel Src Kinase Inhibitor, M475271, Inhibits VEGF-Induced Human Umbilical Vein Endothelial Cell Proliferation and Migration. Journal of Pharmacological Sciences. 98(2). 130–141. 32 indexed citations
12.
Izawa, Yuki, Masanori Yoshizumi, Yoshiko Fujita, et al.. (2005). ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Experimental Cell Research. 308(2). 291–299. 58 indexed citations
13.
Fujita, Yoshiko, Yuki Izawa, Nermin Ali, et al.. (2005). Pramipexole protects against H2O2-induced PC12 cell death. Naunyn-Schmiedeberg s Archives of Pharmacology. 372(4). 257–266. 49 indexed citations
14.
Solomon, Katie, John N. Webb, Nermin Ali, R A Robins, & Yashwant R. Mahida. (2005). Monocytes Are Highly Sensitive toClostridium difficileToxin A-Induced Apoptotic and Nonapoptotic Cell Death. Infection and Immunity. 73(3). 1625–1634. 35 indexed citations
15.
Kyaw, Moe H., Masanori Yoshizumi, Koichiro Tsuchiya, et al.. (2004). Antioxidant Effects of Stereoisomers of N-Acetylcysteine (NAC), L-NAC and D-NAC, on Angiotensin II-Stimulated MAP Kinase Activation and Vascular Smooth Muscle Cell Proliferation. Journal of Pharmacological Sciences. 95(4). 483–486. 18 indexed citations
16.
17.
Ali, Nermin, Masanori Yoshizumi, Koichiro Tsuchiya, et al.. (2003). Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide. European Journal of Pharmacology. 485(1-3). 127–135. 30 indexed citations
18.
Yoshizumi, Masanori, Yoshiko Fujita, Yuki Izawa, et al.. (2003). Ebselen inhibits tumor necrosis factor-α-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Experimental Cell Research. 292(1). 1–10. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingyun Zheng Breakdown of academic impact, for papers by Xiao‐Yan Bai Breakdown of academic impact, for papers by Nelson E. Bruno Breakdown of academic impact, for papers by E Liong Breakdown of academic impact, for papers by Jinge Kong Breakdown of academic impact, for papers by Shengkai Zuo Breakdown of academic impact, for papers by Maria Teresa Rizzo Breakdown of academic impact, for papers by Jutta Meyer-Kirchrath Breakdown of academic impact, for papers by Koji Yamamoto Breakdown of academic impact, for papers by Jingjing Wu
Rankless by CCL
2026